跳到主要內容

Rothblatt Martine A 的 Form 4 申報

United Therapeutics Corp(UTHR),2026/5/22 申報

申報編號
0001106578-26-000059
申報時間
2026/5/22
交易日
2026/5/21
申報延遲
1 天
10b5-1 計畫
有勾選

這份申報列了 9 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $535.9 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Rothblatt Martine ACIK 0001106578董事、高階主管(董事長、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/5/21Common StockM行使選擇權取得+9,500$146.03+$1,387,28550,013直接
2026/5/21Common StockS賣出處分−40$557.85−$22,31449,973直接
2026/5/21Common StockS賣出處分−280$560.03F2−$156,808.449,693直接
2026/5/21Common StockS賣出處分−919$561.97F3−$516,450.4348,774直接
2026/5/21Common StockS賣出處分−1,760$562.98F4−$990,844.847,014直接
2026/5/21Common StockS賣出處分−2,242$563.77F5−$1,263,972.3444,772直接
2026/5/21Common StockS賣出處分−1,840$564.87F6−$1,039,360.842,932直接
2026/5/21Common StockS賣出處分−2,259$566.02F7−$1,278,639.1840,673直接
2026/5/21Common StockS賣出處分−160$566.42F8−$90,627.240,513直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/5/21Common StockM行使選擇權處分−9,500$0.00$0183,410直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $559.99 to $560.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $561.29 to $562.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $562.32 to $563.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades at prices ranging from $563.33 to $564.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $564.34 to $565.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $565.365 to $566.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F8

This transaction was executed in multiple trades at prices ranging from $566.39 to $566.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)